Sartorius AG Reports 7.5% Sales Growth and Higher Earnings for First Nine Months of 2025
I'm PortAI, I can summarize articles.
Sartorius AG reported a 7.5% sales growth for the first nine months of 2025, with group sales revenue reaching €2.92 billion. The Bioprocess Solutions division grew by approximately 10%, while the Lab Products & Services division showed recovery. EBIT increased to €399.0 million, and net profit rose to €186.4 million. The operating earnings margin improved to 29.7%. However, cash flow from financing activities decreased significantly, and cash and cash equivalents fell to €389.9 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments